-
The cost of not rescuing Wall Street
feature What happens if Congress does nothing?
feature -
Wall Street's uncertain future
feature Did Treasury's refusal to save Lehman Brothers from bankruptcy help, or make matters worse?
feature -
Should Wall Street chiefs go to jail?
feature Assigning blame for the financial meltdown
feature -
The fall and rise of Wall Street
feature Does Monday's big stock-market rally mean the worst is over?
feature -
Issue of the week: Has Wall Street been chastened?
feature After bouncing back spectacularly from the 2008 crash, Wall Street just had a very bad year.
feature -
The cost of Occupy Wall Street, and more
feature The movement has cost municipalities at least $13 million in police overtime and other services.
feature -
A linguistic success for Occupy Wall Street, and more
feature
feature -
Issue of the week: Wall Street on trial
feature The insider trading case against Raj Rajaratnam of the Galleon hedge fund involves some of the biggest names in the financial world.
feature -
Why New York City is writing Occupy Wall Street a six-figure check
feature A high-profile police raid is proving quite costly
feature -
Two years later: Did Occupy Wall Street make a difference?
feature Protesters no longer camp out in Zuccotti Park. Does that mean the movement didn't accomplish anything?
feature -
Issue of the week: The Ponzi scheme that’s shaking Wall Street
feature In what may be the largest investment scam in history, Bernard Madoff was charged last week with securities fraud after confessing to running a $50 billion “Ponzi scheme.”
feature -
Occupy Wall Street: Will the crackdown end the movement?
feature As the police continue to dismantle the tent cities of the Occupy movement, its future as a political force is in question.
feature -
Wall Street: The good times are rolling again
feature The big banks are flush with money and plan to give out billions of dollars in annual bonuses to their employees.
feature -
Wall Street discourages drug R&D
feature When Pfizer announced this year that it was slashing spending on research and development, its shares rose more than 5 percent, said Dan Primack at Fortune.
feature
